title: [Why is it sometimes necessary to include a large number of patients in clinical trials?].
authors.affiliation: Institut Gustave-Roussy, Villejuif, France.
authors.forename: C
authors.initials: C
authors.lastname: Hill
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D012107:Research Design
chemical_list: D000319:Adrenergic beta-Antagonists
vernacular_title: Pourquoi est-il parfois nécessaire d'inclure un grand nombre de sujets dans un essai thérapeutique?